23 August, 2021 – Tokyo’s Medical Assoc. Chairman holds live press conference recommending Ivermectin.
Japan’s government is one of the most conservative and cautious in the world. Data is clear. Huge news.
31 July, 2021 – DR JACKIE STONE OF ZIMBABWE SPEAK ABOUT IVERMECTIN IN COMBINATION WITH OTHER DRUGS AGAINST COVID
26 August, 2021 – Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study
In 28 days of follow-up, significant protection of ivermectin preventing the infection from SARS-CoV-2 was observed: 1.8% compared to those who did not take it (6.6%; p-value = 0.006), with a risk reduction of 74% (HR 0.26, 95% CI [0.10,0.71]).
Condensed Summary of the Emerging Evidence Supporting the Use of Ivermectin in the Prophylaxis and Treatment of COVID-19
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens